Journal of Nephropharmacology

Society of Diabetic Nephropathy Prevention

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Journal of Nephropharmacology is an open-access journal published by Society of Diabetic Nephropathy Prevention in Iran, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 400 USD. Declared review time at DOAJ: 4 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Society of Diabetic Nephropathy Prevention
ISSN
2345-4202
Country
Iran
Languages
english
Access
Open access
Declared publication charge
400 USD
Articles in DOAJ
367
Declared review time
4 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2016-02-18
Indexing
DOAJ
APC
400 USD
Declared review time (DOAJ)
4 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

367

Most recent article

5 months ago

Average review time (journal-declared via DOAJ)

4weeks

Works in OpenAlex

261

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

10

i10-index

12

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2022-12-13
Added to DOAJ
2016-02-18
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
20%
ORCID iDs in current deposits
100%
Enrolled in Crossref Similarity Check
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification4

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology

LCC codes

RM1-950RC870-923

Subject areas

  • Renal Diseases and Glomerulopathies
  • Renal Diseases and Glomerulopathies
  • Acute Kidney Injury Research
  • Acute Kidney Injury Research
  • Dialysis and Renal Disease Management
  • Dialysis and Renal Disease Management
  • Chronic Kidney Disease and Diabetes
  • Chronic Kidney Disease and Diabetes
Show all subjects (50)
  • Parathyroid Disorders and Treatments
  • Parathyroid Disorders and Treatments
  • Hemoglobinopathies and Related Disorders
  • COVID-19 Clinical Research Studies
  • Hemoglobinopathies and Related Disorders
  • COVID-19 Clinical Research Studies
  • Muscle and Compartmental Disorders
  • Muscle and Compartmental Disorders
  • Drug-Induced Hepatotoxicity and Protection
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Renal and Vascular Pathologies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Central Venous Catheters and Hemodialysis
  • Drug-Induced Hepatotoxicity and Protection
  • Renal and Vascular Pathologies
  • Central Venous Catheters and Hemodialysis
  • SARS-CoV-2 and COVID-19 Research
  • Systemic Lupus Erythematosus Research
  • Diabetes Treatment and Management
  • Pancreatitis Pathology and Treatment
  • Urinary Tract Infections Management
  • Long-Term Effects of COVID-19
  • Long-Term Effects of COVID-19
  • Urinary Tract Infections Management
  • Pancreatitis Pathology and Treatment
  • Diabetes Treatment and Management
  • Systemic Lupus Erythematosus Research
  • SARS-CoV-2 and COVID-19 Research
  • Metabolism, Diabetes, and Cancer
  • Pharmacological Effects and Toxicity Studies
  • Electrolyte and hormonal disorders
  • Renal Transplantation Outcomes and Treatments
  • Pharmacological Effects and Toxicity Studies
  • Electrolyte and hormonal disorders
  • Renal Transplantation Outcomes and Treatments
  • Metabolism, Diabetes, and Cancer
  • Liver Disease Diagnosis and Treatment
  • Heart Failure Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Heart Failure Treatment and Management
  • Liver Disease Diagnosis and Treatment
  • Blood Pressure and Hypertension Studies

Keywords (DOAJ)

  • nephrology
  • pharmacology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: